Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1319088.
- Also identified by PMC identifier 463753.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Relapse of small cell lung cancer is not usually treated with further chemotherapy as results are considered to be disappointing. Six patients with relapse of small cell lung cancer after a complete initial response and remission of more than one year responded to repeat treatment with the initial chemotherapy comprising carboplatin, etoposide, and epirubicin. The second remission ranged from six months to more than 15 months. In patients with a relapse of small cell lung cancer after a complete initial response and prolonged remission retreatment with the initial combination chemotherapy cannot be dismissed and requires further study.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Small Cell
- Lung Neoplasms
- Neoplasm Recurrence, Local